Introduction {#Sec1}
============

Genetic diversity is a key determinant in modulating human susceptibility to several diseases, including the respiratory infections (Chapman and Hill [@CR3]). The relevance of host genetic background in driving disease phenotypic diversity is also emerging in the context of monogenic diseases characterized by airway infection (Cutting [@CR7]). Based on recent findings, we can now assume that pathogens are not the unique factors determining the wide spectrum of disease outcomes, as there is a considerable contribution from the host genetic background. The relevance of individual genetic variations to *Pseudomonas aeruginosa* infection is emerging in several respiratory illnesses of different etiologies including cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD), or bronchiectasis. *P. aeruginosa* is one of the most common hospital-acquired opportunistic pathogens and mediates extremely variable outcomes of respiratory illnesses (Gellatly and Hancock [@CR16]). So far, human studies have identified candidate genetic loci or modifier genes associated with the disease diversity during *P. aeruginosa* respiratory infection (Weiler and Drumm [@CR40]). In parallel, several studies using animal and ex-vivo models have been carried over to achieve deep understanding of the biological relevance and significance of the host genetic profile in modulating the disease outcome of *P. aeruginosa* respiratory infection. Recently, the use of classical murine inbred strains and new murine resource populations has supported several progressive steps forward in this field, generating new knowledge with a strong translational significance. In this review, we discuss the latest state of the art that mainly covers human and murine studies to define the role of host genetic background and host genetic traits during respiratory infection by *P. aeruginosa*.

Heterogenicity of human populations results in different responses to *P. aeruginosa* infections {#Sec2}
------------------------------------------------------------------------------------------------

Outcomes of *P. aeruginosa* infections in patients with respiratory illnesses are difficult to predict and show a high degree of variability in terms of disease severity, complications and survival (Chapman and Hill [@CR3]; Cutting [@CR7]). The association between genotype and phenotype is difficult to determine in humans due to the small size of cohorts with detailed clinical outcomes that are often influenced by non-genetic contributors, such as environmental and stochastic factors. The most characterized population, affected by respiratory infections, is that suffering from CF genetic disease and followed from birth; their clinical data, including their microbiological status (e.g., *P. aeruginosa*), are periodically recorded. In CF, it has been shown that host genetic factors (e.g., multiple genetic loci or polymorphic variations) influence the progression of *P. aeruginosa* lung infections and age at establishment, regardless of the *Cystic Fibrosis Transmembrane Conductance Regulator* (*CFTR)*-genotype. Two main genetic approaches have been exploited in humans to identify genetic modifiers that directly influence the phenotype of CF disease: (i) an "*a priori*" approach, i.e., the candidate gene approach, where the genes selected for investigation are identified from the current understanding of CF lung disease pathophysiology, and (ii) an "unbiased" approach, analyzing the whole genome or exome sequencing by linkage and genome-wide association studies (GWAS). From the candidate gene studies, several genes have been proposed as potential CF pulmonary disease phenotype modifiers (Weiler and Drumm [@CR40]). These could be classified into different categories including inflammatory response, infection response, and tissue damage and repair.

Genetic association has been found for several phenotypes spanning from the age of first infection, establishment of chronic *P. aeruginosa* infection or particular *P. aeruginosa* phenotypes (e.g., mucoid). First acquisition of airway *P. aeruginosa* has been associated with variants in the mannose-binding lectin 2 (*MBL2*), in the Na^+^/H^+^ exchanger (*SCL9A3)*, in the amino acid transporter (*SLC6A14)* (Dorfman et al. [@CR10], [@CR11]; Pereira et al. [@CR30]) and in the tumor necrosis factor-α (TNF-α) (Coutinho et al. [@CR6]) genes. Significant associations between age-of-onset of chronic *P. aeruginosa* infection have been reported for ficolin (*FNC1, FNC2)*, MBL-associated serine protease *(MASP3*), caveolin-2 *(CAV2)*, and transmembrane-like channel 6 (*TMC6)* genes (Dorfman et al. [@CR10]; Emond et al. [@CR13]; Haerynck et al. [@CR20]). Time to first *P. aeruginosa* airway infection, chronic *P. aeruginosa* infection, and mucoid *P. aeruginosa* have been associated with genetic variants in dynactin protein (*DCTN4)* (Emond et al. [@CR12]). *P. aeruginosa* mucoidy has been associated with pro-inflammatory cytokines interleukin 8 (*IL-8)* gene variants (Furlan et al. [@CR15]). However, even collectively, these human studies only partially explain the contribution of genetic variance to the risk of *P. aeruginosa* airway infection and should be validated in additional cohorts. Similar approaches should also be exploited in other populations affected by *P. aeruginosa* respiratory infection (e.g., COPD).

Acute *P. aeruginosa* infection in resistant and susceptible inbred mouse strains {#Sec3}
---------------------------------------------------------------------------------

Different mouse models of acute respiratory infection by *P. aeruginosa* have been used to dissect the role of genetic backgrounds in determining lung disease severity (Table [1](#Tab1){ref-type="table"}). These models exploited and compared different inbred murine strains during acute pneumonia lasting for hours or at most a few days. In this regard, a comprehensive classification of mouse inbred strains into categories according to their resistance or susceptibility is difficult to achieve. The differences in the disease outcome may be affected by several factors including routes of administration (aerosol vs intratracheal), size of the bacterial load and different *P. aeruginosa* strains used (laboratory vs clinical), length of infection, as well as age, gender and the specific murine sub-strains. Despite these issues, a wide range of disease severity after *P. aeruginosa* infection with some common trends were observed indicating a critical role of the host genetic background in modulating the outcome of the pulmonary disease. Here, we focus mainly on the murine inbred strains most commonly tested in models of *P. aeruginosa* respiratory infection, namely DBA/2, A/J, C3H/He, BALB/c, and C57BL/6 mice (Table [1](#Tab1){ref-type="table"}).

Table 1Different outcomes to *P. aeruginosa* infection in murine inbred strainsMouse strainvs (mouse strain)Acute infectionChronic infectionEx-vivoA/JDBA/2↓ mortality (Wilson et al. [@CR41])↓ bacterial load (Wilson et al. [@CR41])C57BL/6↓ IL-1β production by bone-marrow-derived macrophages (Miao et al. [@CR25])C3H↓ neutrophil recruitment (De Simone et al. [@CR8])↑bacterial load (De Simone et al. [@CR8])↑ mortality (Spagnuolo et al. [@CR36])↑ bacterial persistence (Spagnuolo et al. [@CR36])Early phase≈ neutrophils amount (Spagnuolo et al. [@CR36])↑ bacterial load (Spagnuolo et al. [@CR36])↓ alveolar macrophage numbers (Spagnuolo et al. [@CR36])↓ CD4^+^IL-17^+^ (Spagnuolo et al. [@CR36])≈ CD4^+^IFN-γ^+^ (Spagnuolo et al. [@CR36])Late phase↑ CD4^+^IL-17^+^ (Spagnuolo et al. [@CR36])≈ phagocytic or bactericidal activity of bone-marrow-derived neutrophils and peritoneal macrophages (Spagnuolo et al. [@CR36])BALB/c↓ IL-1β production by bone marrow derived macrophages (Miao et al. [@CR25])↑ splenocytes proliferation (Barclay et al. [@CR1])DBA/2C57BL/6↑ bacterial load (Morissette et al. [@CR26])↓ bactericidal capacity of bone-marrow-derived macrophages (Wilson et al. [@CR41])C3H↑ mortality (Wilson et al. [@CR41])↑ bacterial load (Wilson et al. [@CR41])↑ mortality (Spagnuolo et al. [@CR36])↑ bacterial persistence (Spagnuolo et al. [@CR36])BALB/c↑ mortality (Morissette et al. [@CR26])↑ bacterial load (Morissette et al. [@CR26])Early phase↓ inflammatory cells recruitment (Morissette et al. [@CR26])≈ bactericidal activities of lung macrophages (Morissette et al. [@CR27])C57BL/6BALB/c↑ splenocyte proliferation (Barclay et al. [@CR1])↓ TNF-α production by alveolar macrophages (Sapru et al. [@CR33])↓ proliferation of lung T cells (Stevenson et al. [@CR37])↓ IL-4 and IL-10 production from lung T cells (Kondratieva et al. [@CR21])↑ IFN-γ production from lung T cells (Kondratieva et al. [@CR21])C3HBALB/c↑ IFN-γ production by splenocytes (Moser et al. [@CR28])↓ IL-4 production by splenocytes (Moser et al. [@CR28])

Susceptibility and resistance to *P. aeruginosa* infection were initially based on survival rates and bacterial loads in the lungs followed by additional characterization of immunological phenotypes. In an early extensive study, 11 inbred mouse strains were compared using aerosol models of *P. aeruginosa* infection (Wilson et al. [@CR41]). DBA/2J mice were the most susceptible, while A/J and C3H/HeN were the most resistant when monitored for mortality. In more details, the ability of the DBA/2J strain to contain bacterial growth in the lungs was limited and this supported the role of host genetic makeup in resistance to infections. Wilson et al. affirmed that this severe disease phenotypic trait was due to a limited bactericidal activity when compared with C57BL/6 macrophage cells (Wilson et al. [@CR41]). Of note, these immune-mediated mechanistic conclusions were different to a previous study that focused on the macrophage phagocytic ability in different genetic backgrounds (Morissette et al. [@CR27]), although both studies identified DBA/2J mice as susceptible murine strains.

In a recent extensive study, we compared nine inbred mouse strains, including murine sub-strains, in a pneumonia model system induced by intratracheal delivery of the *P. aeruginosa* clinical strain to define deviant survival phenotypes. The highest susceptibility was observed in A/J and DBA/2J, while BALB/cAnNCrl and C3H/HeOuJ were the most resistant to *P. aeruginosa* infection (De Simone et al. [@CR8]). When distinct sub-strains of BALB/c from Jackson (BALB/cJ and BALB/cByJ) or Charles River (BALB/cAnNCrl) were compared, significant differences between BALB/cAnNCrl and BALB/cByJ were found supporting marked genetic and behavioral differences. A more detailed characterization of immunological phenotype was carried out on A/J and C3H/HeOuJ mice, as the most deviant murine strains (De Simone et al. [@CR8]). When bacterial loads and neutrophils recovered in the lungs were correlated, A/J mice showed a delayed neutrophil recruitment and a higher bacterial burden in the lungs, suggesting their inefficiency to promptly keep the bacterial infection in check compared to C3H/HeOuJ mice. We speculated that A/J mice do not mount a proper, early immune defense leading to a permissive environment for bacterial replication and bacteremia, ultimately leading to rapid disease progression. Furthermore, A/J mice showed an excessive release of pro-inflammatory cytokines that did not correlate with the cellular response, suggesting a defect in leukocyte recruitment. As stated above, variability in the methods of infection (aerosol vs intratracheal) and measurable outcomes (body weight vs mortality vs bacterial load vs inflammation) are two key factors affecting the interpretation of the results. Therefore, a direct comparison among studies should be carefully weighted. Based on the definition of host resistance to infection (Schneider and Ayres [@CR34]), an accurate evaluation of bacterial loads at different post-infection timepoints may represent the most unbiased biological parameter for comparing results across different studies.

Mouse strains presenting deviant disease phenotypes can be further exploited to identify genetic loci underlying host susceptibility to infections of different origins (Gruenheid and Gros [@CR19]; Vidal et al. [@CR39]). While the forward genetic approach has been widely implemented for several pathogens, only one study has applied it to *P. aeruginosa* infection. In this regard, we mated *P. aeruginosa*-resistant C3H/HeOuJ, and susceptible A/J mice and the deriving F2 intercross population was phenotyped and used for quantitative trait locus (QTL) mapping (De Simone et al. [@CR9]). A significant QTL associated with the survival rate was mapped on chromosome 6, and named *P. aeruginosa infection resistance locus 1 (Pairl1)*. Through gene prioritization analysis within the *Pairl1* genomic interval (\~ 20 Mbps), a set of promising candidate disease modifier genes was proposed that mediated host-pathogen sensing, neutrophils and macrophages recruitment, and inflammatory processes.

It is becoming evident that complex combinations and variations of genetic locus/genes affect the outcome of *P. aeruginosa* respiratory infection. Although mouse inbred strains are the starting point for the exploration of causal genotype--phenotype relationships and gene mapping, they do not offer a wide genetic variability for the identification and study of the polymorphic variations that are hallmarks of the human population (Peters et al. [@CR31]). This limits genetic and phenotypic diversity and the value of QTL detection. The new Collaborative Cross (CC) mice population may overcome the limitation of previous genetic mapping approach (Churchill et al. [@CR4]), such as the low mapping resolution based on F2 intercross population. The CC is a murine inbred reference population with high genetic diversity designed by randomly outcrossing eight founder inbred strains, followed by inbreeding processes (<https://csbio.unc.edu/CCstatus/index.py>). It is worth noting that the CC murine population has been used to model infectious diseases caused by a number of different virus and bacteria including Ebola virus (Rasmussen et al. [@CR32]), *Mycobacterium tuberculosis* (Smith et al. [@CR35]), West Nile virus (Graham et al. [@CR17]), Severe Acute Respiratory Coronavirus (SARS-CoV) (Gralinski et al. [@CR18]), influenza A virus (Ferris et al. [@CR14]), and non-typhoidal *Salmonella* (Zhang et al. [@CR43]). In these studies, the power of the CC resource led to the identification of the host genes controlling susceptibility to infections. When we challenged a cohort of 17 different CC murine strains with *P. aeruginosa* into the lung, they displayed a widely marked phenotypic disease variation in terms of mortality (survival rate) and morbidity (changes in body weight). When broad-sense heritability of these phenotypic traits was evaluated, we confirmed the influence of the genetic profile, rather than environmental factors, among CC lines during *P. aeruginosa* infection (Lore et al. [@CR22]). This study confirmed the ability the CC murine population has to mirror human disease diversity in the context of acute lung infection by *P. aeruginosa*. It is evident that the CC population may be exploited to identify genetic loci associated with acute lung infection by *P. aeruginosa*, with a higher mapping resolution in comparison to previous studies.

Susceptibility to chronic *P. aeruginosa* respiratory infection in inbred mouse strains {#Sec4}
---------------------------------------------------------------------------------------

Studies with different inbred mouse strains support the contribution of the host genetic background to predispose the animals to chronic infection and different degrees of disease severity due to a different immunoreactivity to pathogens (Table [1](#Tab1){ref-type="table"}). In this regard, several mouse models of chronic infection have been established by including *P. aeruginosa* clinical isolates in different types of immobilizing agents such as agar, agarose, or seaweed alginate to prevent clearance by the host (Bragonzi [@CR2]). Recently, we exploited the agar-beads mouse model of long-term chronic lung infection, refined and characterized in C57Bl/6NCrl (Cigana et al. [@CR5]), in five phylogenetically different inbred strains of mice to identify deviant disease phenotypes and to dissect the cell-mediated immunity (Spagnuolo et al. [@CR36]). In this study, we classified A/J and DBA/2J as the most susceptible to *P. aeruginosa* chronic infection, while C3H/HeOuJ strains were classified as the most resistant. Several clinical phenotypes including survival rates, weight losses, bacterial loads and capacity to establish long-term chronic infection were considered in this ranking. Other works that focused on chronic infection mediated by bacteria embedded in agar-beads are generally in agreement with this classification and in addition include BALB/c as a resistant murine strain (Morissette et al. [@CR26]; Tam et al. [@CR38]). Moreover, a different classification for C57Bl/6N susceptibility to chronic infection was reported, probably due to the use of different bacterial strains embedded in agar-beads. To define possible causes for predisposition, immune-related events possibly linked to diverse *P. aeruginosa* susceptibility and resistance have been investigated. *Morissette* et al. reported that in a model of *P. aeruginosa* chronic infection, leukocyte recruitment in the early phases of infection was higher in resistant hosts compared to susceptible ones. This could account for a differential predisposition to the development of chronic infection (Morissette et al. [@CR26]; Spagnuolo et al. [@CR36]). In line with this work, we found in the early phase of chronic infection that neutrophils were similar in the lungs of susceptible A/J and resistant C3H/HeOuJ strains, despite higher bacterial loads in susceptible mice; in addition, resistant mice showed higher alveolar macrophage numbers. Immunity mediated by T-helper (Th) cell subsets, such as CD4 + T cells, may play a critical role in host protection vs immunopathology of infectious diseases. Early studies in the seaweed alginate beads model had defined Th1 (IFNγ -producing CD4^+^ T) response of resistant C3H/HeN mice as being associated with a better disease outcome when compared to the Th2 (IL4-producing CD4^+^ T) response of susceptible BALB/c mice (Moser et al. [@CR29], [@CR28]). While the Th1/Th2 paradigm dominated the field of *P. aeruginosa*-associated immunological responses, the discovery of a third subset of IL-17-producing effector Th cells has fostered new hypotheses. Indeed, we have recently demonstrated that the IL-17-mediated immune response may be beneficial in the early phase chronic infection by contrasting *P. aeruginosa*, while its overload can be detrimental in the advanced phase by exacerbating immunopathology (Lore et al. [@CR23], [@CR24]). In line with this report, by comparing different murine inbred strains, we showed that the high clearance of *P. aeruginosa* and the progressive resolution of inflammation in resistant C3H/HeOuJ mice was associated with early superior lung infiltration by an IL17-dominated T-cell response (Spagnuolo et al. [@CR36]). Instead, IL4-producing CD4^+^T cells were negligible in both resistant C3H/HeOuJ and susceptible A/J mice, while levels of IFNγ -producing CD4^+^ T cells were similar in the early stage chronic infection. In the late phase, susceptible A/J mice showed a massive infiltration of the lung by CD4^+^IL17^+^ cells compared to *P. aeruginosa*-resistant strain associated with an exacerbated immunopathology. Thus, host genetic backgrounds predisposing to the modulation of IL17-mediated immunity can determine the outcomes of early and advanced chronic *P. aeruginosa* respiratory infection. These results open up new avenues for translational studies aimed at testing new therapeutic approaches.

As in the context of acute respiratory infection, mouse strains presenting deviant disease and immunological phenotypes can be further exploited to identify genetic loci underlying host susceptibility to chronic respiratory infection. At the time of writing, human and murine studies addressing the role of genetic traits associated with chronic respiratory infection are limited. Thus, future efforts exploiting new murine population (e.g., CC mice) may contribute to new knowledge in this field.

Dissection of mechanisms underlying murine susceptibility to *P. aeruginosa* infection in ex-vivo models {#Sec5}
--------------------------------------------------------------------------------------------------------

The use of ex-vivo models has been exploited but not widely implemented to investigate the cellular/molecular mechanisms underlying the impact of host genetics on the susceptibility to *P. aeruginosa* infection (Table [1](#Tab1){ref-type="table"}). Innate immune recognition and clearance mechanisms play a critical role in controlling *P. aeruginosa*. The host genetic background could influence the neutrophil and macrophage capacity to phagocytize and kill *P. aeruginosa*. Despite an initial increase in phagocytosis, bone-marrow-derived macrophages of susceptible DBA/2 displayed a severely reduced bactericidal capacity compared to those of C57BL/6 macrophages resistant to *P. aeruginosa* infection (Wilson et al. [@CR41]). Differently, the *in vitro* bactericidal activity of resident and inflammatory alveolar and interstitial macrophages recruited did not differ between susceptible DBA/2 and BALB/c mice resistant to *P. aeruginosa* infection (Morissette et al. [@CR27]). The different origins of macrophages (bone marrow vs lung) could explain the different results of these reports. However, in our recent report, we did not find differences either in phagocytizing or bactericidal activities of bone-marrow-derived neutrophils and peritoneal macrophages from susceptible A/J and resistant C3H/HeOuJ mice, suggesting that the different outcomes of diverse genetic backgrounds to *P. aeruginosa* infection cannot be assigned to the bactericidal activity of phagocytosing cells (Spagnuolo et al. [@CR36]). It is worth noting that the tissue origin may account for a different stage of neutrophil differentiation and function. Thus, future studies focusing on neutrophil cells isolated from murine lungs or airways during an inflammatory response should light on the role of the host genetic background in this context.

Immune cells derived from susceptible and resistant mouse strains could produce different amounts of cytokines/chemokines thus impacting on leukocyte recruitment. It has been demonstrated that alveolar macrophages from resistant BALB/c mice produce significantly higher levels of TNF-α following stimulation with heat-killed *P. aeruginosa* compared to those from susceptible C57BL/6 mice (Sapru et al. [@CR33]). Bone-marrow-derived macrophages from A/J mice secrete less IL-1β protein than those from C57Bl/6 and BALB/c mice when stimulated *in vitro* by *P. aeruginosa* (Miao et al. [@CR25]).

The genetic background may also influence T-cell responses. Splenocytes from A/J and C57Bl/6 mice were found to be high responders to proliferation stimulated *in vitro* by *P. aeruginosa* exoenzyme S, while BALB/c mice were low responders (Barclay et al. [@CR1]). Taking into consideration that the authors identified A/J and C57Bl/6 mice as susceptible to *P. aeruginosa* infection and BALB/c mice as resistant, they speculated that lymphocyte proliferation could impair the host response to *P. aeruginosa*. Differently, it has been shown that heat-killed *P. aeruginosa* induced significantly higher *in vitro* proliferative responses of lung T cells from resistant BALB/c than those from susceptible C57Bl/6 mice (Stevenson et al. [@CR37]). However, the differences between the last two reports could result from the origin of T cells (spleen vs lung) as well as the use of different *P. aeruginosa* factors. Afterwards, the latter group showed that T-cell clones derived from lymph nodes and lungs of different mouse strains produced different cytokines following treatment with heat-killed *P. aeruginosa*. T-cell clones from resistant BALB/c mice produced more IL-4 and IL-10 and were annotated as Th2-like cells, while those from susceptible C57Bl/6 mice produced more IFN-γ and were considered Th1-like cells (Kondratieva et al. [@CR21]). Other studies on ex-vivo polarization of Th cells from different mouse strains showed divergent results. Splenic cells from resistant C3H/HeN mice produced more IFN-γ following stimulation with *P. aeruginosa* outer membrane protein, while those from susceptible BALB/c mice produced more IL-4 (Moser et al. [@CR28]). The Th1 polarization in resistant mouse strains is in line with the observation that this type of response is commonly associated with *P. aeruginosa* clearance or with a milder course of the infection (Yonker et al. [@CR42]).

It is clear from these ex-vivo studies that several contrasting results have been reported probably reflecting the complexity of the host---*P. aeruginosa* interplay. Differences among studies may reflect experimental models of infection, the inbred mouse sub-strains, the use of different *P. aeruginosa* strains or its products, the type of cells stimulated, their physical origin, the timing and other unconsidered confounders.

Conclusions {#Sec6}
===========

The relevance of the inter-individual genetic variation, intended as the diversity of host genetic backgrounds or host genetic modifier locus/i, has emerged in the context of respiratory infection by *P. aeruginosa*. Several proofs have been produced thanks to the complementary findings of both human and animal studies. However, additional efforts are required to clearly identify the candidate host genetic modifier locus/i with translational potential. As discussed in this review, genetics-based variability in the disease outcomes evidenced by animal models, and in particular different inbred murine strains, represents important progress in the field, at least in the context of *P. aeruginosa* infection. Overall, these studies highlight how mouse models can be exploited to mirror host genetic diversity and the associated host defense variations. Future studies may exploit CC mice and mouse models of *P. aeruginosa* infection and will reveal genetic loci associated with the severity of acute or chronic lung infection as previously demonstrated for other respiratory pathogens (Ferris et al. [@CR14]; Gralinski et al. [@CR18]). Further efforts should aim at confirming the potential biological and translational relevance in humans in the context of respiratory infection induced by *P. aeruginosa*. Regarding rare monogenic diseases characterized by airway infection (e.g., CF), new mouse models mirroring inter-individual genetic variation are essential to advance or complement human studies, currently limited by the small size of cohorts and phenotypic data. Once more, the CC or the Diversity Outbred (DO) mice represent strong tools for the future to model genetic diversity of monogenic diseases, providing new knowledge in this research area.

Moreover, refined mouse models of infection may prove to be essential to determine the relevance of genetic diversity in modulating differential activation of the immune system during *P. aeruginosa* respiratory infection. As we discussed in this review, previous studies had highlighted the potential role of mouse inbred strains in this field, although they do not completely reflect the host genetic variability in humans. In this regard, to our knowledge, no data from ex-vivo studies on CC- or DO-derived cells stimulated by *P. aeruginosa* have been published. However, the availability of powerful tools, as CC and DO mice, may be essential to associate in vivo phenotypic descriptive investigations to in vitro mechanistic studies in these populations to identify pathways involved in the host susceptibility to *P. aeruginosa* lung infection.

In conclusion, further efforts are required to correlate human and animal data. The technological advancement of DNA sequencing and analysis both in humans and animals has given a significant boost to studies in this field. This will allow the scientific community to identify novel candidate modifiers of genetic loci or genes with a translational clinical relevance in the context of *P. aeruginosa* respiratory infection.
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